Acetylsalicylic acid aggravates anaphylaxis in a PGE2-dependent manner
Open Access
- 31 December 2024
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (5)
Abstract
Acetylsalicylic acid (ASA) can exert proanaphylactic effects, but the extent of this phenomenon and its underlying mechanisms are undefined. Yet, low homeostatic prostaglandin E 2 (PGE 2 ) levels have been associated with anaphylaxis. In this study, we investigated whether the proanaphylactic effect of ASA is PGE 2 dependent. We assessed the effect of ASA in experimental anaphylaxis models, analyzed a large dataset of patients with anaphylaxis, and performed titrated allergen challenges in ASA-treated allergic individuals. Registry data indicated an increased risk for severe anaphylaxis in patients with ASA comedication. ASA pretreatment aggravated allergen-dependent anaphylaxis in mice, whereas histamine-induced anaphylaxis remained unaffected. Exacerbation was due to reduced PGE 2 , as its stabilization or the use of prostanoid E receptor (EP) agonists reversed the proanaphylactic effects of ASA. EP2-, EP3-, and EP4 receptor–deficient mice revealed that each receptor individually contributed to ASA susceptibility. In patients with allergy, prior ASA intake increased skin responsiveness to allergen but not to histamine. Conversely, the responses of basophils to ex vivo FcεRI aggregation remained unaltered, indicating that ASA operated by enhancing the stimulability of mast cells in a PGE 2 -dependent manner. Collectively, our data reveal a central role of the PGE 2 network in ASA-aggravated anaphylaxis. EP receptors could be potential targets to prevent or alter the outcome of anaphylaxis.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (WO541/16-2)
This publication has 52 references indexed in Scilit:
- Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMPThe Journal of Immunology, 2004
- Incidence of anaphylaxis with circulatory symptoms: a study over a 3‐year period comprising 940 000 inhabitants of the Swiss Canton BernClinical & Experimental Allergy, 2004
- Prostaglandin E2 as a mediator of fever: synthesis and catabolismFrontiers in Bioscience-Landmark, 2004
- Receptors and Signaling Mechanisms Required for Prostaglandin E2-Mediated Regulation of Mast Cell Degranulation and IL-6 ProductionThe Journal of Immunology, 2002
- The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxisJournal of Allergy and Clinical Immunology, 2002
- Cyclooxygenase Inhibition Increases Interleukin 5 and Interleukin 13 Production and Airway Hyperresponsiveness in Allergic MiceAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptorNature Medicine, 1999
- Cardiovascular Effects of Histamine Infusion in ManJournal of Cardiovascular Pharmacology, 1983
- Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responsesJournal of Allergy and Clinical Immunology, 1981
- Augmentation of allergic histamine release from human leukocytes by nonsteroidal anti-inflammatory—analgesic agentsJournal of Allergy and Clinical Immunology, 1980